富含二十碳五烯酸(EPA)或二十二碳六烯酸(DHA)之飲食對老化促進小鼠(SAMP8)在強迫游水實驗模式下行為表現之影響

Effects of EPA- or DHA-riched Diets on Behavior Performance under Forced Swimming Test Model in Senescence Accelerated-Prone 8 Mice

黃俊傑(Jun-Jie Huang)

指導教授 ： 黃士懿

臺北醫學大學/公共衛生暨營養學院/保健營養學研究所/碩士(2010年)

https://doi.org/10.6831/TMU.2010.00040

摘要

根據世界衛生組織(World Health Organization, WHO)的流行病學調查指出，憂鬱症在2030年將成為世界第一的高負擔疾病，而年齡大於65歲的老年人比青壯年族群更易罹患憂鬱症。研究指出造成老年人憂鬱症的原因可能為神經退化所導致，進而影響了神經訊息傳導物質濃度降低與認知功能喪失等。本實驗將探討富含二十碳五烯酸(eicosapentaenoic acid；EPA)及二十二碳六烯酸(docosahexaenoic；DHA)之飲食對於雄性老化促進小鼠Senescence accelerated-prone 8 (SAMP8)行為表現之影響。實驗期間分別給予五月齡大54隻SAMP8小鼠富含大豆油(基礎組、控制組及正控制組-投予抑鬱劑imipramine)、富含EPA之魚油(EPA>60%)及DHA之魚油(DHA>50%)的飲食，共計五組。各組實驗組經十二週的飲食介入後進行強迫游水試驗(forced swimming test, FST )分析並犧牲，分析其血漿、紅血球及腦部前額葉皮質之脂肪酸組成，並分析腦部前額葉皮質之單胺氧化酶-A和-B (monoamine oxidase A & B, MAO-A & MAO-B)活性及腦衍生神經滋養因子(brain derived neurotrophic factor, BDNF)濃度。於強迫游水試驗中發現，EPA組及DHA組其靜止時間顯著低於控制組(p<0.05)，而腦衍生神經滋養因子濃度與控制組相比顯著提高(p<0.05)；此兩者結果呈現顯著負相關，推測EPA及DHA可能因BDNF的濃度而間接改善FST所引發之類似憂鬱情境。EPA及DHA組之MAO-A活性顯著低於控制組(p<0.05)，而EPA組之MAO-B活性顯著低於控制組(p<0.05)，推測可能藉由降低MAO-A&B的活性而減少神經傳導物質的代謝，進而改善憂鬱情境。因此本次研究結果發現，富含EPA及DHA之飲食可能改善老化促進小鼠於壓力環境下類似憂鬱情境之行為表現，同時發現EPA改善的效果高於DHA。

關鍵字

憂鬱症 ； 二十碳五烯酸 ； 二十二碳六烯酸 ； 強迫游水試驗

並列摘要

The recent epidemiological data of World Health Organization (WHO) pointed out that unipolar depressive disorder will become one of the high burdens of disease in 2030. The age over 65-year-old elderly is more likely to suffer depression than young ethnic groups. Recent reports show that elderly depression may result in the aging of neural degeneration, decrease the level of neurotransmitters and transmission of nerve signals and/or disability cognitive function eventually. In this study, we aimed to assess the eicosapentaenoic acid- (EPA-) and docosahexaenoic acid-rich (DHA-rich) diets protective effect on behavior test in aging male senescence accelerated-prone 8 (SAMP8) mice. Fifty-four 5-month-old aged SAMP8 mice were housed and fed with the various diets, which including soybean-oil-riched diet groups (base group, control group and the positive control group, imipramine-injected group), EPA-riched and (EPA>60%) and DHA-riched (DHA>50%) diet groups. After 12-week dietary intervention, animals were evaluated by behavior tset (under forced swimming test; FST), sacrificed and blood and selected organ for further biochemical analyses. The fatty acid profiles of plasma, erythrocyte and brain prefrontal cortex were analyzed. The monoamine oxidase A & B (MAO-A & MAO-B) activity and the level of brain derived neurotrophic factor (BDNF) concentration in brain were also examined. Results of the force swimming test showed that EPA- and DHA-rich groups showed significant shorter immobile time than the control group (p<0.05) and EPA-rich group showed significant higher BDNF level than control group (p<0.05). Both results showed highly significant negative correlation, it is reasonably to presume the anti-depressive effect of EPA and DHA may depend on the level of BDNF and EPA, DHA may indirectly improve depression-like behavior under FST. The decreasing MAO-A activity was observed in EPA and DHA group, and the EPA group of MAO-B activity significantly lower than the control group (p<0.05). It’s possible by reducing MAO-A & MAO-B activity and resulted to restore neurotransmitters metabolism, which may direct and/or indirect improve the depression-like behavior. In conclusion, this study found that EPA- and DHA-riched dietary may improve the SAMP8 mice under pressure which presents the antidepressant-like behavior ability, specifically in EPA-riched diet.

並列關鍵字

depression ； EPA ； DHA ； forced swimming test

參考文獻

69. Su KP: Mind-body interface: the role of n-3 fatty acids in psychoneuroimmunology, somatic presentation, and medical illness comorbidity of depression. Asia Pac J Clin Nutr 2008, 17 Suppl 1:151-157.

86. Chang CY, Ke DS, Chen JY: Essential fatty acids and human brain. Acta Neurol Taiwan 2009, 18(4):231-241.

1. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE: Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62(6):617-627.

2. Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349(9064):1498-1504.

3. The global burden of disease. In.: World Health Organization; 2008.